| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WST | Common Stock | Options Exercise | $692K | +8.02K | +190.53% | $86.24* | 12.2K | May 1, 2023 | Direct | |
| transaction | WST | Common Stock | Sale | -$2.69M | -7.37K | -60.27% | $365.55 | 4.86K | May 1, 2023 | Direct | F1 |
| transaction | WST | Common Stock | Sale | -$238K | -649 | -13.36% | $366.14 | 4.21K | May 1, 2023 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WST | Stock Options (Right to Buy) | Options Exercise | $0 | -8.02K | -100% | $0.00* | 0 | May 1, 2023 | Common Stock | 8.02K | $86.24 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $365.00 to $365.91, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| F2 | The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $366.0350 to $366.18, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| F3 | This award vests in 4 equal annual installments beginning on 2/26/2019. |